As a leading hub for biomedical and translational research, QBRI continues to actively leverage common interests through partnerships and long-term collaborations with renowned national and international institutions of the highest caliber. These alliances enable the institute to transcend borders, build expertise, and strengthen research capacity in Qatar.
QBRI has successfully established and continues to pursue collaborations and strategic partnerships with distinguished scientists and research institutions to advance scientific progress. These collaborations not only drive discovery but also accelerate research development and lead to advancements in biomedical research, advancing our capacity for innovation. Our efforts focus on key areas such as biology, medicine, biomarker discovery, and precision medicine.
Alongside research, QBRI remains committed to fostering community engagement and increasing public awareness of critical health issues such as autism, breast cancer, and diabetes.
Our partners and collaborators within Qatar are Hamad Medical Corporation, the Shafallah Center, Sidra Medicine, Qatar University, Weill Cornell Medicine – Qatar, Anti-Doping Lab Qatar, Carnegie Mellon University – Qatar, Primary Health Care Corporation, and Qatar Precision Health Institute. Key collaborations extend to the Qatar Cancer Society, Qatar Diabetes Association, and Ranad Academy. Internationally, we are proud to collaborate with the King Hussein Cancer Center, the University College of London, the Silverstein Foundation, F. Hoffman-La Roche Ltd, Sultan Qaboos University, Cleveland Clinic Foundation, and Lundbeck.
These partnerships empower QBRI to drive innovative research and provide impactful healthcare solutions both locally and globally.
Apply Now 
